Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

The Motley Fool July 29, 2011 Sean Williams	Another Day, Another Loss For Cell Therapeutics Cell Therapeutics is giving shareholders that sinking feeling.
InternetNews February 9, 2011	Nokia CEO Warns of Sinking Smartphone Business In an all-hands memo, Nokia head Stephen Elop issues a dire warning about the company's eroding position in the market next to Google and Apple.
The Motley Fool January 27, 2011 Anders Bylund	As Predicted, Nokia Sinks Can the former cell phone giant change quickly enough?
InternetNews February 4, 2011 Stuart J. Johnston	Nokia, Microsoft Hook-Up Rumors Swirl Stock analyst's open letter to Microsoft and Nokia execs details how a proposed deal would benefit both firms.
The Motley Fool September 11, 2010 Anders Bylund	Did Nokia Make the Right Choice? The Finnish telecom giant snags a new CEO from the top ranks of Microsoft.
The Motley Fool February 4, 2011 Tim Beyers	Nokia's U.S. Survival Strategy Reveals Its Weaknesses Two years after Nokia officially pooh-poohed the idea of a Windows phone, new CEO Stephen Elop may be considering exactly that here in the U.S.
The Motley Fool May 4, 2011 Brian Orelli	Cell Therapeutics: Denied but Not Rejected Cell Therapeutics' ball may be headed for the end zone, but the FDA has an eight-foot free safety ready to bat it down.
The Motley Fool January 29, 2010 Anders Bylund	The Worst Stock of 2010 Strikes Back Kodak kicks like a mule when it's supposed to be down.
The Motley Fool September 17, 2010 Luke Timmerman	Cell Therapeutics OK'd to Sell Shares to Stay Alive Is the company being straight with shareholders?
BusinessWeek November 20, 2006 Arlene Weintraub	Is Cell Therapeutics In Remission? Battered biotech Cell Therapeutics' controversial CEO has won over Novartis, but investors are wary.
The Motley Fool July 13, 2011 David Williamson	Roundtable: The Biggest Risks in Biotech Three biotech companies to steer clear of.
InternetNews February 10, 2011	Nokia Ready to Call on Microsoft? Rumors are heating up that a Nokia/Microsoft alliance related to mobile devices will be announced this Friday.
The Motley Fool July 21, 2005 Alyce Lomax	Kodak's Not-So-Pretty Picture It appears tough times are still ahead for Kodak. Yesterday, its shares dropped precipitously, but that drop eased over the course of the day.
InternetNews February 11, 2011 Stuart J. Johnston	Nokia Looks to Windows Phone 7 Details of the surprising alliance between Microsoft and Nokia begin to emerge
InternetNews September 10, 2010	Microsoft's Elop Takes CEO Spot at Nokia Struggling handset heavyweight Nokia shows Olli-Pekka Kallasvuo the door, replacing him with the president of Microsoft's Business Division, Stephen Elop.
BusinessWeek May 10, 2004 Faith Arner	No Excuse Not To Succeed How COO Antonio Perez is hustling Kodak into the Digital Age.
The Motley Fool June 15, 2011 Brian Orelli	Investors Need a Peephole Into FDA Offices Cell Therapeutics is gung ho about its resubmission, but investors only get one side of the story.
The Motley Fool October 26, 2011 Dan Radovsky	Can Microsoft Save Nokia? Nokia introduces its Windows Phone to the world.
The Motley Fool January 24, 2011 Sean Williams	Eastman Kodak: Bargain Buy or Value Trap? Eastman Kodak's valuation essentially boils down to one question: What is the Kodak name worth, in relation to a lagging business model and the potential of intellectual property pacts in the future?
The Motley Fool May 27, 2011 Brian Orelli	What Kind of Phase 2 Drug Can You Get for $5 Million? Cell Therapeutics issues a press release saying the company has identified a potential acquisition opportunity that is a phase II drug candidate.
The Motley Fool September 15, 2010 Brian Orelli	Cell Therapeutics Goes for Broke If Cell Therapeutics can't get new funding soon, long-term consequences may be the least of its worries; time on the clock looks to be running out.
The Motley Fool September 21, 2011 John Grgurich	Get Smart With This Undervalued Stock Nokia stock is down but definitely not out.
The Motley Fool January 4, 2012 Brian Orelli	Mark Your Calendars, Biotech Investors Cell Therapeutics' advisory panel meet ought to be entertaining.
The Motley Fool October 24, 2011 Sean Williams	Kodak Answers the Age-Old Question: How Much Is a Picture Worth? The answer appears to be a $900 million bridge loan.
The Motley Fool September 28, 2011 Brian Orelli	One Step Closer to an FDA Decision Cell Therapeutics is still risky, though.
The Motley Fool August 13, 2009 Tim Beyers	Nokia Gets a New Office There is no established business productivity suite for smartphones. Microsoft, the PC leader in this area, is now positioned to be the mobile leader.
The Motley Fool June 14, 2011 Anders Bylund	Nokia Scores a Hollow Victory Apple and Nokia ended their nearly two-year-old web of crosswise lawsuits with an anticlimactic settlement.
The Motley Fool November 18, 2010 Anders Bylund	It's Not Too Late to Save Nokia It just takes some tough love.
The Motley Fool December 12, 2011 Dan Caplinger	Why 2011 Crushed Eastman Kodak Let's look back at how the year went for this company.
The Motley Fool January 19, 2012 Sean Williams	Eastman Kodak's Flash Goes Dark: What It Means for You The once-iconic photography company declares bankruptcy.
BusinessWeek June 2, 2011 Peter Burrows	Stephen Elop's Nokia Adventure Market share dwindling, stock cratering, persistent takeover talk. How the CEO is trying to lead Nokia past its epic fail.
BusinessWeek February 19, 2007 Spencer E. Ante	A Totally Different Picture Kodak's new line of inkjet printers is a critical piece of its business model.
The Motley Fool February 10, 2011 Rick Aristotle Munarriz	Don't Buy Nokia, Microsoft Microsoft and Nokia don't make a lot of sense as a couple.
The Motley Fool June 12, 2011 Anders Bylund	Should You Buy Nokia at These Bargain-Basement Prices? Nokia stock may look like a steal today, but only if you believe in a turnaround.
The Motley Fool October 28, 2011 John Grgurich	1 Stock Reaching the Danger Point It's do-or-die time for Nokia.
InternetNews September 13, 2010	Where Does Elop's Departure Leave Microsoft? Stephen Elop's decision to head to Finland to take the top spot at Nokia robs Microsoft of the leader of its lucrative Office product line. How strong is the bench?
BusinessWeek May 28, 2009 Catherine Arnst	Make-or-Break Time for Cancer Drugs Strong presentations at the key oncology conference in late May will be crucial for struggling biotechs.
The Motley Fool January 21, 2010 Rich Duprey	The Worst Stocks for 2010: Eastman Kodak A picture of this company may not be worth a thousand words.
The Motley Fool December 31, 2011 Brian Orelli	3 Stock-Moving Binary Events to Watch in 2012 Binary events, FDA decisions, and clinical trial results, are the lifeblood -- and death wish -- of the biotech industry. Here are three to watch in 2012.
InternetNews December 20, 2010	Is Microsoft Calling Nokia for Windows Phone 7? One hot rumor has the software and mobile giants discussing the possible addition of Windows Phone 7 to Nokia's lineup of mobile devices.
The Motley Fool July 22, 2010 Anders Bylund	Why Nokia Keeps Slip-Sliding Away Cheap and easy sales are great -- until the underdeveloped markets become developed.
The Motley Fool February 8, 2011 Anders Bylund	Nokia May Join the Dark Side Getting Nokia into the Android camp is like making a Sith lord out of Luke Skywalker.
The Motley Fool June 15, 2005 Brian Gorman	Cell Therapeutics' Gamble The biotech company's struggles are far from over. Without an approved drug on the market or the certainty of FDA clearance, the firm won't have an easy time finding investors.
The Motley Fool December 31, 2011 David Williamson	2011 Review: Cell Therapeutics After starting the year at a split-adjusted $2.22 a share, Cell Therapeutics stock lost almost 50% of its value by the end of December, closing at $1.16. How did we get here?
The Motley Fool August 16, 2011 Rich Duprey	Kodak Inks Another Patently Absurd Idea Going from film maker to a printer company is proving more difficult than Kodak thought.
The Motley Fool July 1, 2011 Sean Williams	Patent Ruling Leaves Kodak Stuck in Still-Frame If one more wheel falls off this wagon, there won't be any left.
The Motley Fool February 2, 2010 Rich Duprey	Bury Kodak, Don't Praise It Kodak remains a picture of a company in contraction, not expansion.
InternetNews March 28, 2011	Kodak CEO Hopes for $1 Billion in Patent Suit Eastman Kodak's head told Bloomberg he thinks a patent victory in court could bring in $1 billion. Kodak sued Apple and RIM in January 2010 for what it claims is infringement of a patent it holds in the area of previewing images in iPhone and Blackberry mobile devices.
The Motley Fool April 21, 2011 Anders Bylund	Color Me Unimpressed, Nokia The first-quarter report Nokia published this morning was a small step in the right direction. But by "small," think "minuscule."
The Motley Fool November 27, 2010 Anders Bylund	Can Nokia Pull Out a Stateside Smartphone Win? Nokia won't make it big in America until it cozies up with the big service providers.